Insight
Life Sciences Snapshot – Q4 2024 – A Quarterly Report on Financing Trends
14 minute read | December.20.2024
Healthtech Horizons: Navigating Regulation, Investment, and Strategy in a Transforming Market
Life Sciences Snapshots
In this report series, we explore trends in venture investing across the life sciences sector, featuring data provided by PitchBook.
Insight
Life Sciences Snapshot – Q3 2024 – A Quarterly Report on Financing Trends
28 minute read | October.07.2024
Navigating ARPA-H
Insight
Life Sciences Snapshot – Q2 2024 – A Quarterly Report on Financing Trends
21 minute read | June.26.2024
Novel Approaches to Treating Neurodegenerative Diseases
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q1 2024
25 minute read | February.26.2024
Women's & Reproductive Health
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q4 2023
22 minute read | November.10.2023
Leveraging Alternative Financing
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2023
20 minute read | July.25.2023
Venture Funding and Tech Trends in AI in Drug Discovery
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2023
26 minute read | April.25.2023
This edition of Orrick’s life sciences publication series reviews key trends of venture investment in the life sciences industry during Q1 2023.
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q1 2023
16 minute read | February.14.2023
Venture Funding and Tech Trends in Mental Health
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q4 2022
23 minute read | October.24.2022
Leveraging Non-Dilutive Financing For Drug Development and Favorably Licensing Developed Products as a Global Health Model
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2022
23 minute read | July.27.2022
Evolving Antitrust Scrutiny of Life Sciences M&A—What's in the Pipeline?
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2022
April.26.2022
A Conversation on Leveraging Spinouts to Preserve and Create Value During Financing Rounds, M&A and IPO Planning
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q1 2022
22 minute read | February.16.2022
A Conversation on the Future of Longevity, Cell Regeneration and Senescence
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q4 2021
23 minute read | October.19.2021
VC Investment Surges in European Life Science
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2021
14 minute read | July.21.2021
A Conversation on Spinouts – Unlocking Market Value and Creating Business Opportunities
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2021
22 minute read | April.20.2021
Record-breaking Markets and a Candid Conversation on University Spinouts
Insight
Life Sciences Snapshot ‐ A Quarterly Report on Financing Trends ‐ Q1 2021
18 minute read | February.01.2021
We review full-year 2020 data in depth to identify and summarize the key trends that shaped venture investment across the sector.
Insight
Life Sciences Snapshot ‐ A Quarterly Report on Financing Trends ‐ Q3 2020
9 minute read | October.22.2020
Venture Surges and the Rise of SPACs
In this edition, the traditional update on broader venture market financing data is included.
In this edition, the traditional update on broader venture market financing data is included.
Insight
Life Sciences Snapshot ‐ A Quarterly Report on Financing Trends ‐ Q2 2020
10 minute read | August.10.2020
Companies & Investors Navigate the Pandemic Era
In this new series, we explore trends in venture investing across the life sciences sector.
In this new series, we explore trends in venture investing across the life sciences sector.
Insight
Life Sciences Snapshot ‐ A Quarterly Report on Financing Trends ‐ Q1 2020
12 minute read | May.11.2020
The Market Meets COVID-19
In this new series, we explore trends in venture investing across the life sciences sector.
In this new series, we explore trends in venture investing across the life sciences sector.